Results 13,201-13,220 of 26,396 for speaker:David Cullinane

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Yes, but at that point Mr. Breen was not in a position to give us an estimated cost. Given the passage of time and the fact that there are now five settled claims, can he give us a breakdown of the cost to the State for non-disclosure in the five settled claims?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I know all of that, but------

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: This concerns accepted liability. I am asking what the cost to the State has been thus far of cases where the State has accepted liability. Surely Mr. Breen is in a position to give me the overall figure for that liability, rather than breaking it down case by case.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Does Mr. Breen not have it at his disposal?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Can he give it to us during the course of the day? I could ask for a second speaking slot if so.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I am talking about the State's liability in settled cases concerning non-disclosure, not upon a case-by-case basis but the overall sum.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: This briefing note, which is very good, includes a breakdown of the overall number of active claims, broken down into bands up to €1 million, €1 million to €4 million and so on, and the amount involved. That is quite helpful. There are 3,365 claims, with an estimated liability of €3.57 billion. Is that correct?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Do those 3,365 active claims include the 85 CervicalCheck claims?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Can Mr. Breen give us the overall estimated liability for those 85 claims?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: One could argue the same logic about giving us the overall figure of €3.57 billion for 3,365 cases.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: To be clear, Mr. Breen is saying that he can reveal that there are 3,365 active claims for medical negligence generally, with an estimated liability for the State of €3.57 billion. While the 85 claims for CervicalCheck are included in that, Mr. Breen is not able to give us a breakdown of what the estimated liability for them will be. It goes back to the point that Teachta Connolly...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Mr. Breen is not in a position to do so.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: When will we know what that liability is or even get an estimate of it? Are we ever going to know?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: When?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: That was helpful. We will come back to the issue. I appreciate the point Mr. Breen is making but at the same time we are looking at what this will cost the State in overall terms and we would like some sense of what the liability will be. I can somewhat understand what Mr. Breen is saying, but it would be very helpful to us and the women involved to have some understanding of what the...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: Is Mr. Breen saying that in some cases the laboratory indemnifies the State for non-disclosure as well?

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: I am only asking about non-disclosure and the liability therefor.

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: The Chair can pick up on this. My question concerned the liability of the State for non-disclosure, where we are not indemnified by the labs, what the estimated liability is and what the actual liability has been so far. Mr. Breen has given reasons that this information cannot be given to us, but we will come back to it. I want to return to the issue of breaking down the figures into...

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: That is grand. We do not want to be unfair, and we do not want to create unfair difficulties for any clinician or give rise to any perception that might not reflect reality. We do not want a headline to say there is a problem in a hospital where there is not. I completely understand that. At the same time, we need some kind of metrics by which we can determine whether there is a problem....

Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)

David Cullinane: We will await the additional breakdown, on receipt of which we will examine it again. In his 2012 report the Comptroller and Auditor General examined the issue of legal costs. Page 36 of the 2016 annual report of the NTMA, details the cost of State Claims Agency claims resolved between 2012 and 2016. It shows that in 2016 the average total legal cost per clinical claim was...